EPCORE NHL-1 follicular lymphoma (FL) cycle (C) 1 optimization (OPT) cohort: Expanding the clinical utility of epcoritamab in relapsed or refractory (R/R) FL

Lunenburg Lymphoma Phase Cons I; Kim M. Linton

doi:10.1200/JCO.2024.42.16_suppl.7015

EPCORE NHL-1 follicular lymphoma (FL) cycle (C) 1 optimization (OPT) cohort: Expanding the clinical utility of epcoritamab in relapsed or refractory (R/R) FL

Lunenburg Lymphoma Phase Cons I, Kim M. Linton

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Number of pages	1
Journal	Journal of Clinical Oncology
Volume	42
Issue number	16
Early online date	29 May 2024
DOIs	https://doi.org/10.1200/JCO.2024.42.16_suppl.7015
Publication status	Published - 1 Jun 2024
Event	American Society of Clinical Oncology (ASCO) Annual Meeting 2024 - McCormick Place, Chicago, United States Duration: 31 May 2024 → 4 Jun 2024 https://meetings.asco.org/meetings/2024-asco-annual-meeting/316/program-guide/scheduled-sessions

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/JCO.2024.42.16_suppl.7015

Cite this

@article{8e8db8b3a04847d98b613fced1ca09e6,

title = "EPCORE NHL-1 follicular lymphoma (FL) cycle (C) 1 optimization (OPT) cohort: Expanding the clinical utility of epcoritamab in relapsed or refractory (R/R) FL",

author = "{Lunenburg Lymphoma Phase Cons I} and Julie Vose and Umberto Vitolo and Pieternella Lugtenburg and Chamuleau, {Martine E. D.} and Linton, {Kim M.} and Catherine Thieblemont and Kristina Sonnevi and Wojciech Jurczak and Olszewski, {Adam J.} and Awan, {Farrukh Tauseef} and Okada, {Craig Y.} and Feldman, {Tatyana A.} and Martin Hutchings and Elena Favaro and Daniela Hoehn and Zhu Li and Rebekah Conlon and Juan-Manuel Sancho and Chavez, {Julio C.}",

year = "2024",

month = jun,

day = "1",

doi = "10.1200/JCO.2024.42.16_suppl.7015",

language = "English",

volume = "42",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "16",

note = " American Society of Clinical Oncology (ASCO) Annual Meeting 2024, 2024 ASCO Annual Meeting ; Conference date: 31-05-2024 Through 04-06-2024",

url = "https://meetings.asco.org/meetings/2024-asco-annual-meeting/316/program-guide/scheduled-sessions",

}

TY - JOUR

T1 - EPCORE NHL-1 follicular lymphoma (FL) cycle (C) 1 optimization (OPT) cohort

T2 - American Society of Clinical Oncology (ASCO) Annual Meeting 2024

AU - Lunenburg Lymphoma Phase Cons I

AU - Vose, Julie

AU - Vitolo, Umberto

AU - Lugtenburg, Pieternella

AU - Chamuleau, Martine E. D.

AU - Linton, Kim M.

AU - Thieblemont, Catherine

AU - Sonnevi, Kristina

AU - Jurczak, Wojciech

AU - Olszewski, Adam J.

AU - Awan, Farrukh Tauseef

AU - Okada, Craig Y.

AU - Feldman, Tatyana A.

AU - Hutchings, Martin

AU - Favaro, Elena

AU - Hoehn, Daniela

AU - Li, Zhu

AU - Conlon, Rebekah

AU - Sancho, Juan-Manuel

AU - Chavez, Julio C.

PY - 2024/6/1

Y1 - 2024/6/1

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pure_starter&SrcAuth=WosAPI&KeyUT=WOS:001275557401665&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1200/JCO.2024.42.16_suppl.7015

DO - 10.1200/JCO.2024.42.16_suppl.7015

M3 - Meeting Abstract

SN - 0732-183X

VL - 42

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 16

Y2 - 31 May 2024 through 4 June 2024

ER -

EPCORE NHL-1 follicular lymphoma (FL) cycle (C) 1 optimization (OPT) cohort: Expanding the clinical utility of epcoritamab in relapsed or refractory (R/R) FL

UN SDGs

Access to Document

Other files and links

Cite this